CIMDUO

NDC 49502-450 · Viatris Specialty LLC

Generic nameLamivudine and Tenofovir Disoproxil Fumarate

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE

Strength300; 300 mg/1; mg/1

Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]

Marketing categoryNDA

Packages

49502-450-93 — 1 BOTTLE, PLASTIC in 1 CARTON (49502-450-93) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42291-800 — Tenofovir Disoproxil Fumarate, 42291-980 — Emtricitabine and Tenofovir Disoproxil Fumarate, 42385-801 — emtricitabine, rilpivirine and tenofovir disoproxil fumarate, 42385-915 — Efavirenz, emtricitabine and tenofovir disoproxil fumarate, 42385-928 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-929 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-953 — Emtricitabine and Tenofovir Disoproxil Fumarate, 42385-962 — Abacavir and Lamivudine, 42543-719 — EMTRICITABINE and TENOFOVIR Disoproxil Fumarate, 43063-900 — LAMIVUDINE and ZIDOVUDINE, 49502-475 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 49702-202 — lamivudine and zidovudine, 49702-203 — lamivudine, 49702-204 — lamivudine, 49702-205 — lamivudine, 49702-231 — abacavir sulfate, dolutegravir sodium, lamivudine, 49702-246 — dolutegravir sodium and lamivudine, 50090-6494 — Emtricitabine and Tenofovir Disoproxil Fumarate, 50090-7202 — Tenofovir Disoproxil Fumarate, 50090-7719 — Emtricitabine and tenofovir disoproxil fumarate, +117 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.